| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:00:26 UTC |
|---|
| Update Date | 2020-02-26 21:39:14 UTC |
|---|
| HMDB ID | HMDB0013913 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 8-Hydroxynevirapine |
|---|
| Description | 8-Hydroxynevirapine belongs to the class of organic compounds known as alkyldiarylamines. These are tertiary alkylarylamines having two aryl and one alkyl groups attached to the amino group. In humans, 8-hydroxynevirapine is involved in the nevirapine metabolism pathway. 8-Hydroxynevirapine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a small amount of articles have been published on 8-Hydroxynevirapine. |
|---|
| Structure | CC1=C2NC(=O)C3=C(N=CC(O)=C3)N(C3CC3)C2=NC=C1 InChI=1S/C15H14N4O2/c1-8-4-5-16-14-12(8)18-15(21)11-6-10(20)7-17-13(11)19(14)9-2-3-9/h4-7,9,20H,2-3H2,1H3,(H,18,21) |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C15H14N4O2 |
|---|
| Average Molecular Weight | 282.2973 |
|---|
| Monoisotopic Molecular Weight | 282.111675712 |
|---|
| IUPAC Name | 2-cyclopropyl-13-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one |
|---|
| Traditional Name | 2-cyclopropyl-13-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=C2NC(=O)C3=C(N=CC(O)=C3)N(C3CC3)C2=NC=C1 |
|---|
| InChI Identifier | InChI=1S/C15H14N4O2/c1-8-4-5-16-14-12(8)18-15(21)11-6-10(20)7-17-13(11)19(14)9-2-3-9/h4-7,9,20H,2-3H2,1H3,(H,18,21) |
|---|
| InChI Key | DZPVEPLRIKDBFC-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as alkyldiarylamines. These are tertiary alkylarylamines having two aryl and one alkyl groups attached to the amino group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic nitrogen compounds |
|---|
| Class | Organonitrogen compounds |
|---|
| Sub Class | Amines |
|---|
| Direct Parent | Alkyldiarylamines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alkyldiarylamine
- Pyrido-para-diazepine
- Para-diazepine
- Methylpyridine
- Hydroxypyridine
- Imidolactam
- Pyridine
- Heteroaromatic compound
- Vinylogous amide
- Carboxamide group
- Lactam
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Azacycle
- Organoheterocyclic compound
- Organic oxygen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.49 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.4344 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.17 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 28.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 907.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 219.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 110.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 145.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 62.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 344.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 459.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 115.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 718.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 109.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1281.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 212.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 288.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 391.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 138.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 153.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 8-Hydroxynevirapine,1TMS,isomer #1 | CC1=CC=NC2=C1NC(=O)C1=CC(O[Si](C)(C)C)=CN=C1N2C1CC1 | 2818.2 | Semi standard non polar | 33892256 | | 8-Hydroxynevirapine,1TMS,isomer #2 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O)=CN=C1N2C1CC1 | 2616.6 | Semi standard non polar | 33892256 | | 8-Hydroxynevirapine,2TMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[Si](C)(C)C)=CN=C1N2C1CC1 | 2579.8 | Semi standard non polar | 33892256 | | 8-Hydroxynevirapine,2TMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[Si](C)(C)C)=CN=C1N2C1CC1 | 2695.7 | Standard non polar | 33892256 | | 8-Hydroxynevirapine,2TMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[Si](C)(C)C)=CN=C1N2C1CC1 | 3650.5 | Standard polar | 33892256 | | 8-Hydroxynevirapine,1TBDMS,isomer #1 | CC1=CC=NC2=C1NC(=O)C1=CC(O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 3016.8 | Semi standard non polar | 33892256 | | 8-Hydroxynevirapine,1TBDMS,isomer #2 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O)=CN=C1N2C1CC1 | 2864.1 | Semi standard non polar | 33892256 | | 8-Hydroxynevirapine,2TBDMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 2967.0 | Semi standard non polar | 33892256 | | 8-Hydroxynevirapine,2TBDMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 3087.7 | Standard non polar | 33892256 | | 8-Hydroxynevirapine,2TBDMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 3713.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 8-Hydroxynevirapine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0gyd-1890000000-3cfd1974629bed42b767 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 8-Hydroxynevirapine GC-MS (1 TMS) - 70eV, Positive | splash10-002k-4869000000-743bd151da9f4be4e422 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 8-Hydroxynevirapine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 8-Hydroxynevirapine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 10V, Positive-QTOF | splash10-001i-0090000000-4db90e3c8eec102dc152 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 20V, Positive-QTOF | splash10-001i-1090000000-6ea3809a97c81c186d3b | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 40V, Positive-QTOF | splash10-002f-9170000000-3221a4376c5aba7ebc60 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 10V, Negative-QTOF | splash10-001i-0090000000-083099581e2882f2398a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 20V, Negative-QTOF | splash10-001l-0090000000-84dc076d6a97aa601ae1 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 40V, Negative-QTOF | splash10-05bg-1490000000-58b85aee49066a9e29e2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 10V, Negative-QTOF | splash10-001i-0090000000-d72761c0346bc09759b0 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 20V, Negative-QTOF | splash10-001i-0090000000-4b8c21e2532f34918702 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 40V, Negative-QTOF | splash10-03di-1490000000-e98fafeba7360778c678 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 10V, Positive-QTOF | splash10-001i-0090000000-7c900f9f8b3f17914393 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 20V, Positive-QTOF | splash10-001l-0090000000-f426dd3b9af984da0078 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine 40V, Positive-QTOF | splash10-004i-0190000000-ab9dbb520cbde3aefc95 | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|